Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Area9 Lyceum is a global leader in adaptive learning technology, specifically designed to improve proficiency and performance in high-stakes industries such as healthcare and life sciences. The company's flagship platform, Area9 Rhapsode, utilizes artificial intelligence and cognitive science to create personalized learning experiences that identify and close knowledge gaps. In the medical sector, Area9 partners with prestigious institutions like the New England Journal of Medicine to provide advanced clinical education and board preparation. Their services extend to pharmaceutical and biotech companies for sales training, compliance, and clinical trial education. By focusing on "four-dimensional" learning, the company aims to develop not just knowledge, but also skills, character, and meta-learning capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Area9 Lyceum.